17 February 2021
Hyperuricaemia and gout in New Zealand rural and urban Mori and non-Mori communities
Eating slowly and stopping as soon as you feel comfortably full may also reduce digestive discomfort
If you think tirzepatide may not be right for you, you can look at other GLP-1 or GLP-1/GIP medications: Semaglutide (Ozempic, Wegovy) is a GLP-1 receptor agonist that works in a similar way as tirzepatide (a dual GIP/GLP-1 receptor agonist) to help with blood sugar control and weight loss, but it is a different molecule and may be a better match for some patients
In people living with obesity, this natural GLP-1 signaling system is often impaired or insufficient the brain does not receive proper satiety signals, appetite remains elevated, and the metabolic processes that regulate fat storage become dysregulated
Participants taking the highest approved 25mg dose lost an average of 17% of their starting body weight over 64 weeks, when used alongside a reduced-calorie diet and increased physical activity, and treatment was taken as intended